-+ 0.00%
-+ 0.00%
-+ 0.00%

Arch Biopartners Engages Oak Hill Financial for Investor Relations and Marketing Services

PUBT·11/18/2026 13:10:53
Listen to the news
Arch Biopartners Engages Oak Hill Financial for Investor Relations and Marketing Services
  • Arch Biopartners engaged Oak Hill Financial for investor relations and marketing services to broaden investor awareness of its kidney drug programs.
  • Monthly advisory fees total C$ 12,000, excluding applicable taxes and preapproved expenses; no common shares or other securities will be issued as compensation.
  • The initial three-month agreement automatically renews monthly unless terminated with at least five days' written notice.
  • The engagement remains subject to TSX Venture Exchange approval.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arch Biopartners Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611180810PRIMZONEFULLFEED9880257) on November 18, 2026, and is solely responsible for the information contained therein.